Clinical trial
An Observational Study Assessing the Clinical Effectiveness of VeriStrat and Validating Immunotherapy Tests in Subjects With Non-Small Cell Lung Cancer
NCT03289780 is registered in ClinicalTrials.gov with Biodesix, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Study Assessing the Clinical Effectiveness of VeriStrat and Validating Immunotherapy Tests in Subjects With Non-Small Cell Lung Cancer
- Lead sponsor
- Biodesix, Inc.
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- April 4, 2016
- Completion date
- December 31, 2025
- Enrollment
- 5,006 (actual)
- Sites
- 42
Conditions
As the registry lists them; a condition with its own page is linked.
non-small cell lung cancer